EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 100 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.23 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,649,000 | -69.1% | 219,000 | -74.1% | 0.22% | -73.0% |
| Q2 2022 | $5,330,000 | -18.0% | 846,000 | +8.0% | 0.83% | -0.8% |
| Q1 2022 | $6,499,000 | +355.8% | 783,000 | +266.7% | 0.84% | +277.5% |
| Q3 2021 | $1,426,000 | -21.6% | 213,519 | 0.0% | 0.22% | -20.7% |
| Q2 2021 | $1,819,000 | -3.8% | 213,519 | 0.0% | 0.28% | -17.9% |
| Q1 2021 | $1,890,000 | -17.2% | 213,519 | +15.0% | 0.34% | +13.3% |
| Q4 2020 | $2,282,000 | -40.7% | 185,719 | -60.7% | 0.30% | -85.2% |
| Q3 2020 | $3,847,000 | -35.4% | 472,558 | -23.8% | 2.04% | -39.9% |
| Q2 2020 | $5,954,000 | +116.1% | 620,266 | +53.1% | 3.39% | +5.9% |
| Q1 2020 | $2,755,000 | -10.0% | 405,207 | +97.3% | 3.21% | +8.6% |
| Q4 2019 | $3,060,000 | – | 205,407 | – | 2.95% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 1,787,091 | $20,462,000 | 6.02% |
| INTERWEST VENTURE MANAGEMENT CO | 1,599,592 | $18,315,000 | 3.89% |
| NEXTHERA CAPITAL LP | 263,600 | $3,018,000 | 1.54% |
| SPHERA FUNDS MANAGEMENT LTD. | 385,301 | $4,412,000 | 0.86% |
| RA Capital Management | 354,200 | $4,056,000 | 0.50% |
| DAFNA Capital Management LLC | 35,977 | $412,000 | 0.35% |
| Boxer Capital, LLC | 138,331 | $1,584,000 | 0.35% |
| SABBY MANAGEMENT, LLC | 238,907 | $2,735,000 | 0.15% |
| Monashee Investment Management LLC | 31,500 | $361,000 | 0.14% |
| Lombard Odier Asset Management (USA) Corp | 100,000 | $1,145,000 | 0.11% |